Literature DB >> 13312697

Mecamylamine, a new, orally effective, hypotensive agent; experimental and clinical evaluation.

E D FREIS, I M WILSON.   

Abstract

Entities:  

Keywords:  CAMPHOR/derivatives; HYPERTENSION/therapy

Mesh：

Substances：

Year:  1956        PMID： 13312697     DOI： 10.1001/archinte.1956.00250230045005

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  2 in total

1.  Clinical pharmacokinetics of the nicotinic channel modulator dexmecamylamine (TC-5214) in subjects with various degrees of renal impairment.

Authors:  Sofie Alverlind; Stéphane Barassin; Per Dalén; Yan Li; Steven Toler; Hans Eriksson; Raj Tummala
Journal:  Clin Drug Investig       Date:  2014-07       Impact factor: 2.859

2.  Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.

Authors:  S Rahman; Z Zhang; R L Papke; P A Crooks; L P Dwoskin; M T Bardo
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.